TREN NO FURTHER A MYSTERY

There were documented extreme cases of peliosis hepatis, in some cases linked to liver failure and intra-abdominal hemorrhage; liver tumors, often lethal; and blood lipid adjustments linked to greater danger of atherosclerosis led FDA to eliminate acceptance in June 2023. Supplemental warnings involve the dangers connected to cholestatic hepatitis,